Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Multinational, Cross Sectional Primary Data Collection Study to Describe Symptoms Around 24-hs and Their Relationship With Adherence to Respiratory Treatment, Direct Costs and Patient Reported Outcomes (PRO) in Stable COPD Patients in Latin America.

NCT02789540 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02789540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02789540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Multinational, Cross Sectional Primary Data Collection Study to Describe Symptoms Around 24-hs and Their Relationship With Adherence to Respiratory Treatment, Direct Costs and Patient Reported Outcomes (PRO) in Stable COPD Patients in Latin America.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 10, 2016
Completion date
October 31, 2016
Enrollment
900 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

stable copd patients